NFKB1 and prostate cancer: Kunitz-type protease inhibitor 1 (or hepatocyte growth factor activator inhibitor type 1, HAI-1) malfunction promotes intestinal carcinogenesis by activating NF-κB signalling [72]. Low HAI-1 expression is a significant predictor for poor prognosis in prostate cancer [73].